Marpai (MRAI) Stock Price

Marpai Price

NASDAQ·CLOSED
3.21
​
Market closed

Revenue has compounded at 38.7% per year over the past 5 years to 18.10 M USD. Marpai's net margin stands at -91.5%, up from -112.4% several years earlier. Analysts set a median price target of 6.12 USD, implying 90.7% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Marpai stock price

Access this data via the Eulerpool API

Marpai business model & stock analysis

Marpai Inc is a US-based company operating in Insurance industry. The company is headquartered in Tampa, Florida and currently employs 303 full-time employees. The company went IPO on 2021-10-27. Marpai, Inc. is a technology-driven healthcare company, which uses artificial intelligence (AI) and data analytics. The firm provides administrative services and acts as a third-party administrator (TPA) to self-insured employers who provide healthcare benefits to their employees. The Company’s clients are small and medium-sized companies, as well as local government entities. The company provides services to a total of over 41,000 of its client’s employees, including their spouses and dependents. The company serves a total of approximately 73,000 members in 44 states in addition to the District of Columbia. The Company’s AI-powered TopCare program became live, making it possible for it to offer care management with predictions. The Company’s wholly owned subsidiaries include Marpai Captive, Inc., Marpai Administrators, LLC, Marpai Health, Inc., EYME Technologies, Ltd. and Maestro Health, LLC.

Frequently asked questions about Marpai

Analysts currently set an average price target of 6.12 USD for the Marpai stock (median: 6.12 USD), implying +90.7 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Marpai stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Marpai share trades at 2.86 EUR (3.21 USD).

The Marpai share (MRAI) is listed on 1 stock exchanges, including: NASDAQ (MRAI).

The revenue cannot currently be calculated for Marpai.

The profit cannot currently be calculated for Marpai.

The P/E ratio cannot be calculated for Marpai at the moment.

The P/S cannot be calculated for Marpai currently.

The Eulerpool Quality Score for Marpai is 2/10.

The ISIN of Marpai is US5713542083. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Marpai is MRAI. The ticker symbol is used to trade Marpai shares on the stock exchange.

Fair ValueTerminal
2.99 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Insurance
Number of shares
Employees
Revenue per Employee
59,732.67 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Oct 27, 2021
ISIN
US5713542083
Cusip
571354208
Market capitalization
76.65 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
12.50
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
72.19 %
Last updated Oct 9, 2026, 10:11 PM

Marpai Peer Group

Marpai Ticker

NASDAQ · MRAI

Marpai FIGI

MRAI:US · BBG011WQW2R4MRAI:UA · BBG011WQW2S3MRAI:UC · BBG011WQW2T2MRAI:UN · BBG011WQW2W8MRAI:UP · BBG011WQW2X7MRAI:UB · BBG011WQW2Z5MRAI:UM · BBG011WQW310MRAI:UX · BBG011WQW329MRAI:UR · BBG011WQW338MRAI:UD · BBG011WQW374MRAI:UF · BBG011WQW3B9MRAI:VY · BBG011WQW3C8

All fundamentals and in-depth analysis of Marpai

Our stock analysis for Marpai stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Marpai. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.